for the index during January, it had put a cap on the market during February until now.
The rally was broad-based, with every sector bar materials contributing to the rally, including stocks that are usually less sensitive to swings in economic optimism.
Supporting the day's gains was a late surge by pharmaceutical company Reckitt Benckiser, up 3 percent after striking a deal to sell Bristol-Myers Squibb drugs in Latin America.
"The stock was rampant all of last year, and the market obviously likes this deal," Curr said.
"I don't know whether you'd want to be buying it right here though, as it's a nice safe stock ... If things started to get a bit more ugly, however, it might be a stock that you'd want to go back to."
($1 = 0.6385 British pounds)